Better Base Editing in Plants
Better Base Editing in Plants
Adenine editing enzymes have been adapted for use in plants.
Better Base Editing in Plants
Better Base Editing in Plants

Adenine editing enzymes have been adapted for use in plants.

Adenine editing enzymes have been adapted for use in plants.

CRISPR/Cas
Infographic: Plant Genome Editors Get A New Tool
Infographic: Plant Genome Editors Get A New Tool
Ruth Williams | Feb 1, 2019
Adenine editing enzymes have been adapted for use in plants.
Clones Made of CRISPRed Monkeys
Clones Made of CRISPRed Monkeys
Carolyn Wilke | Jan 25, 2019
Researchers edited macaque embryos to induce symptoms of sleep disorders and chose one animal to clone. A bioethicist questions the study’s appropriateness.
First Successful Gene Drive in Mammals
First Successful Gene Drive in Mammals
Abby Olena | Jan 23, 2019
Researchers use a CRISPR-Cas9 strategy to expand a desired trait from 50 percent of mouse pups to about 72 percent.
Taming the Transposon Hordes
Taming the Transposon Hordes
Ruth Williams | Jan 1, 2019
Researchers repurpose the CRISPR machinery to turn whole classes of transposable elements on or off.
Photos of the Year
Photos of the Year
Carolyn Wilke | Dec 21, 2018
From 500-million-year-old fat to a newly discovered virus, here are some stunners from The Scientist in 2018.
Claim of First Gene-Edited Babies Triggers Investigation
Claim of First Gene-Edited Babies Triggers Investigation
Catherine Offord | Nov 26, 2018
He Jiankui says he has successfully used CRISPR-Cas9 to tweak the genes of twins born earlier this month. Some independent experts are dubious.
CRISPR Editing Heads Off Disease in Mouse LiversCRISPR Editing Heads Off Disease in Mouse Livers
CRISPR Editing Heads Off Disease in Mouse Livers
Shawna Williams | Oct 9, 2018
Separate proof-of-concept studies report success against two inherited diseases.
New Technique Limits CRISPR-Cas9 Off-Target Mutations
New Technique Limits CRISPR-Cas9 Off-Target Mutations
Abby Olena | Sep 12, 2018
A mouse study details a method called VIVO that predicts the accuracy of any guide RNA.
Federal Court Sides with Broad in CRISPR Patent Dispute
Federal Court Sides with Broad in CRISPR Patent Dispute
Jef Akst | Sep 10, 2018
The higher court’s decision to uphold the ruling of the Patent Trial and Appeal Board essentially ends the intellectual property battle in the US.